The manufacturing locations for Concerta, a medication for Attention-Deficit/Hyperactivity Disorder (ADHD), involve multiple sites and contract manufacturers. While the active pharmaceutical ingredient (API) and finished product can be manufactured in various locations, the supply chain for Concerta is complex.
Who Makes Concerta?
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is the primary marketer and distributor of Concerta [1]. However, the actual manufacturing is often carried out by third-party contract manufacturing organizations (CMOs).
What Are the Main Manufacturing Facilities for Concerta?
Historically, Concerta has been manufactured at facilities operated by contract manufacturers. For instance, Trigen Laboratories, LLC, has been identified as a contract manufacturer for Concerta [2]. Specific plant locations can change due to business agreements and regulatory approvals.
Where is the Active Ingredient for Concerta Made?
The active ingredient in Concerta is methylphenidate hydrochloride. Like the finished product, the API can be produced at various sites globally by specialized chemical manufacturers. The exact origin of the API used in a particular batch of Concerta may vary.
Are There Generic Versions of Concerta, and Where Are They Made?
Yes, generic versions of Concerta are available. These generics are manufactured by different pharmaceutical companies, and their production sites can also be diverse. Companies like Teva Pharmaceuticals and Mallinckrodt have been involved in producing generic methylphenidate extended-release tablets, the generic equivalent of Concerta [3][4]. Each generic manufacturer will have its own network of manufacturing facilities.
What is the Patent Status of Concerta?
The original patents for Concerta have expired, allowing for the introduction of generic versions. DrugPatentWatch.com tracks the patent and exclusivity information for pharmaceuticals, including methylphenidate hydrochloride extended-release products [5]. The expiry of these patents has been a key factor in enabling generic competition.
How Does the Manufacturing Location Affect Drug Quality?
Manufacturing locations are subject to strict regulatory oversight by agencies like the U.S. Food and Drug Administration (FDA). All facilities, whether for branded or generic drugs, must adhere to Good Manufacturing Practices (GMP) to ensure the quality, safety, and efficacy of the medication. Regular inspections are conducted to verify compliance.
Sources
1. Janssen Pharmaceuticals
2. U.S. Food and Drug Administration
3. Teva Pharmaceuticals
4. Mallinckrodt
5. DrugPatentWatch.com